Recent Clinical Trials Related to VTE
Dr. Geoff Barnes discusses recent clinical trials that relate to VTE and treatment options.
September 18, 2019
There are many different treatments available for blood clots. Some patients are put on medications, such as warfarin or DOACs. Other patients receive mechanical interventions, such as filters.
Arm yourself with the knowledge you need be be informed about your healthcare decisions.
August 14, 2019
Update on Venous Thromboembolism (VTE) Prevention and Treatment
Dr. Alec Schmaier discusses an update on various treatment options for pulmonary embolism (PE) and deep vein thrombosis (DVT). He explores…
June 19, 2019
Update on Anticoagulant Reversal Agents
Dr. Margaret Fang presents an update on anticoagulant reversal agents.
February 20, 2019
Hot Topics in CTEPH: A Review of CTEPH Diagnostics, BPA, and IVC Filters
Dr. Welker interviews Dr. Auger regarding diagnosis and recent treatment options for CTEPH.
December 12, 2018
Bleeding on Anticoagulants
Dr. Sam Berkman discusses the bleeding risk in patients on an anticoagulant in NATF’s December 2018 online support group.
November 26, 2018
Shared Decision Making
It is important for patients to have a voice in the decision-making process regarding their blood clot treatments. Dr. Geoffrey…
November 7, 2018
A DOAC Deep Dive: Edoxaban
Updated October 2019 For the past several decades, warfarin has been the go-to anticoagulant (blood thinner) for doctors, but new…
October 30, 2018
Clot Chronicles: Rivaroxaban’s New FDA Approval
Hello. This is Dr. Sam Goldhaber. I am president of NATF and today on the Clot Chronicles, we are going…
October 26, 2018
How much do you know about blood clots?
How much do you know about blood clots? NATF is working hard to spread awareness and save lives!
September 26, 2018
CTEPH Online Support Group – September 2018
Drs. James Welker and William Auger host NATF’s September 2018 CTEPH online support group.
September 17, 2018
Clot Chronicles: Atrial Fibrillation Awareness Month
September is Atrial Fibrillation Awareness Month! In this episode of the Clot Chronicles, Dr. Sam Goldhaber discusses impact of atrial…
September 5, 2018
DOAC Reversal Deep Dive: A Look At Andexanet Alfa
By Katelyn Sylvester, PharmD, CACP, BCPS For the past several decades, warfarin has been the only FDA-approved oral anticoagulant for…